跳至主要内容
临床试验/ChiCTR-TRC-12002619
ChiCTR-TRC-12002619进行中(未招募)不适用

前瞻性隨機比較傳統體表定位胸椎旁麻醉及超聲波引導胸椎旁麻醉的血流動力學差異

Nil1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 1990年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
36
试验地点
1
主要终点
segmental sensory blockade and the incidence of hypotension

研究概览

简要总结

前瞻性隨機比較傳統體表定位胸椎旁麻醉及超聲波引導胸椎旁麻醉的血流動力學差異

研究设计

研究类型
干预性研究
主要目的
随机平行对照

入排标准

年龄范围
18 至 60(—)
性别
Female

入选标准

  • ASA 1-3 adult female patients undergoing major breast cancer surgery.

排除标准

  • Patients with a known allergy to local anaesthetic drugs Patient with infection at the site of block placement Patient with a bleeding tendency or with evidence of coagulopathy Patient with pre-existing neurological or muscular disorders. Patient with history of psychiatric illness. Pregnant patients Patients with known hypertension (140mmHg or 90mmHg) or poorly controlled hypertension Patients with ischemic heart disease, peripheral vascular disease, carotid artery stenosis, history of TIA stroke Patients with previous chest surgeries radiotherapy/chemotherapy.

研究组 & 干预措施

Two groups

Ropivaicane 0.5% 100 mg Thoracic paravertebral block, once, From thoracic paravertebral block till 48 hours post operatively, versus None

(to be continued)

Ropivaicane 0.5% 100 mg Regional aesthetic block once only. From thoracic paravertebral block till 48 hours post operatively

结局指标

主要结局

segmental sensory blockade and the incidence of hypotension

时间窗: after the thoracic paravertebral block till the end of operation

次要结局

  • Sensation to cold (ice) at regular intervals(5, 10, 20, 30 and 40 min after the paravertebral injection over the ipsilateral and contralateral chest, axilla and abdomen.)
  • Pain score, nausea score, analgesia, antiemetics and vasopressor use(at recovery room till 48 hours at postoperative ward.)

研究者

发起方
Nil

研究点 (1)

Loading locations...

相似试验